公开(公告)号：US20210000849A1

公开(公告)日：2021-01-07

申请号：US17026616

申请日：2020-09-21

Applicant: GLYCOM A/S

Inventor： Bruce MCCONNELL ,  Emma ELISON ,  Louise Kristine VIGSNÆS

IPC: A61K31/702 ,  A23L33/00 ,  A23L33/15 ,  A61P25/22 ,  A61P25/24

Abstract: A synthetic composition for use in treating or improving one or more emotion and/or mood disorders in a patient, characterised in that the composition contains an effective amount of one or more neutral human milk oligosaccharides, is disclosed.

公开(公告)号：US20180369260A1

公开(公告)日：2018-12-27

申请号：US15771189

申请日：2016-10-28

Applicant: GLYCOM A/S

Inventor： Bruce MCCONNELL ,  Emma ELISON ,  Louise Kristine VIGSNÆS

IPC: A61K31/702 ,  A61P1/00 ,  A23L33/15 ,  A61P25/24 ,  A61P25/22

Abstract: A synthetic composition for use in improving one or more co-morbid mental disorder symptoms of a patient with IBS, characterised in that the composition contains an effective amount of one or more neutral human milk oligosaccharides, is disclosed.

公开(公告)号：US20180303858A1

公开(公告)日：2018-10-25

申请号：US15771652

申请日：2016-10-28

Applicant: GLYCOM A/S

Inventor： Bruce MCCONNELL ,  Emma ELISON ,  Louise Kristine VIGSNÆS

IPC: A61K31/702 ,  A61P25/24 ,  A61P25/22 ,  A23L33/15 ,  A23L33/00

Abstract: A synthetic composition for use in treating or improving one or more emotion and/or mood disorders in a patient, characterised in that the composition contains an effective amount of one or more neutral human milk oligosaccharides, is disclosed.